My watch list
my.bionity.com  
Login  

3,591 Current news from the ressort products

rss

You can refine your search further. Select from the filter options on the left to narrow down your results.

image description
FDA Provides Emergency Use Authorization to PerkinElmer for COVID-19 Testing

25-Mar-2020

PerkinElmer, Inc. announced that the U.S. Food and Drug Administration (FDA) has provided Emergency Use Authorization (EUA) for the Company’s New Coronavirus RT-PCR test. Clinical laboratories certified under Clinical Laboratory Improvement Amendments (CLIA) can immediately begin using this kit ...

more

Roche initiates Phase III clinical trial of Actemra/RoActemra in hospitalised patients with severe COVID-19 pneumonia

24-Mar-2020

Roche announcedthat it are working with the Food & Drug Administration (FDA) to initiate a randomised, double-blind, placebo-controlled Phase III clinical trial in collaboration with the Biomedical Advanced Research and Development Authority (BARDA), a part of the US Health and Human Services ...

more

Abbott Receives FDA Emergency Use Authorization and Launches Test to Detect Novel Coronavirus

Company scaling up production at its U.S. manufacturing location

20-Mar-2020

Abbott announced that the U.S. Food and Drug Administration has issued Emergency Use Authorization (EUA) for the company's molecular test for novel coronavirus (COVID-19). Abbott is immediately shipping 150,000 Abbott RealTime SARS-CoV-2 EUA tests to existing customers in the U.S. The tests are ...

more

image description
Pfizer and BioNTech to Co-develop Potential COVID-19 Vaccine

20-Mar-2020

Pfizer Inc. and BioNTech SE announced that the companies have agreed to a letter of intent regarding the co-development and distribution (excluding China) of a potential mRNA-based coronavirus vaccine aimed at preventing COVID-19 infection. The companies have executed a Material Transfer and ...

more

QIAGEN launches coronavirus test kit in Germany following derogation by BfArM

19-Mar-2020

QIAGEN announced that it has obtained derogation in Germany by the Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM) for its newly developed QIAstat-Dx Respiratory SARS-CoV-2 Panel test to be sold as an in vitro diagnostic (“IVD”) for the detection of SARS-CoV-2. At the same time, the ...

more

image description
Evonik achieves major biotech breakthrough with a new animal-free and fermentation-based collagen platform

Recombinant collagen mimics attributes of human collagen

19-Mar-2020

Evonik announced the development of an advanced collagen platform that is made via fermentation-based processes and devoid of animal- or human-derived materials. The recombinant technology will, for the first time, provide pharmaceutical, medical, cell culture and tissue engineering markets with ...

more

image description
CureVac rejects current rumors of an acquisition

Company focuses on the development of mRNA-based coronavirus vaccine to protect people worldwide

16-Mar-2020

CureVac AG confirmed that internal efforts are focused on the development of a coronavirus vaccine with the goal to reach, help and to protect people and patients worldwide. As a consequence, the company is in contact with especially CEPI and many other organizations and authorities worldwide, ...

more

image description
Roche’s cobas SARS-CoV-2 Test to detect novel coronavirus receives FDA Emergency Use Authorization

Test results in three and half hours

13-Mar-2020

Roche announced that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for the cobas® SARS-CoV-2 Test. It is intended for the qualitative detection of SARS-CoV-2, the virus that causes COVID-19 disease, in nasopharyngeal and oropharyngeal swab samples ...

more

image description
Sugar as a remedy for the common cold

Start-up developing therapies to combat viral infections

11-Mar-2020

Viral infections are currently more topical than ever. Not only are coronavirus and influenza constantly in the news but it is also the season for colds – and, as we all know, colds are caused by rhinovirus. A Medical University of Vienna start-up, "G.ST Antivirals GmbH" now has viral infections ...

more

Mologic awarded c.£1 million by UK government to develop rapid diagnostic test for COVID-19

09-Mar-2020

Mologic Ltd announced that it has been awarded circa £1 million by the Wellcome Trust and the Department for International Development (DFID), as part of the UK government’s £46 million international coronavirus (COVID-19) prevention and research funding package. The funding will be used by ...

more

Page 3 From 360
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE